A triple combination of atorvastatin, celecoxib and tipifarnib strongly inhibits pancreatic cancer cells and xenograft pancreatic tumors

Author:                        

Publisher: Spandidos Publications

ISSN: 1019-6439

Source: International Journal of Oncology, Vol.44, Iss.6, 2014-01, pp. : 2139-2145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next